1. |
Dogterom EJ, Wagenmakers MAEM, Wilke M, et al. Mucolipidosis type II and type III: a systematic review of 843 published cases. Genet Med, 2021, 23(11): 2047-2056.
|
2. |
Velho RV, Harms FL, Danyukova T, et al. The lysosomal storage disorders mucolipidosis type II, type III alpha/beta, and type III gamma: update on GNPTAB and GNPTG mutations. Hum Mutat, 2019, 40(7): 842-864.
|
3. |
Oussoren E, van Eerd D, Murphy E, et al. Mucolipidosis type III, a series of adult patients. J Inherit Metab Dis, 2018, 41(5): 839-848.
|
4. |
Wang RY, Bodamer OA, Watson MS, et al. Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals. Genet Med, 2011, 13(5): 457-484.
|
5. |
Kollmann K, Pestka JM, Kühn SC, et al. Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II. EMBO Mol Med, 2013, 5(12): 1871-1886.
|
6. |
Cathey SS, Leroy JG, Wood T, et al. Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands. J Med Genet, 2010, 47(1): 38-48.
|